Go Back
Innoviva, Inc. reports $34.9 million Q1 profit
By USInMinutes - May 10, 2023, 08:20 AM ET
Last Updated - Jul 18, 2023, 03:32 PM EDT
The company generated $76.40 million in quarterly revenue
Innoviva, Inc. [INVA] has reported fiscal Q1 profit of $34.90 million.
On a per-share basis, the DE based company said its diluted earnings are $0.42.
The Pharmaceutical Preparations firm posted revenue of $76.40 million in this period.
Also Read:
- Innoviva Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
- Innoviva Announces Retirement of Board Chairman
- Sulbactam-Durlobactam Unanimously Recommended for Approval by FDA Advisory Committee
- Innoviva Announces FDA Acceptance and Priority Review of New Drug Application for Sulbactam-Durlobactam (SUL-DUR)
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News